Terms: = Germ cell tumor AND RAC1, ENSG00000136238, 5879, MIG5, MGC111543, P63000, p21-Rac1, TC-25 AND Diagnosis
12 results:
1. Primary mucosal melanomas of the urogenital tract: a clinical, pathological, and genetic nationwide survey of Danish patients 1990-2019.
Znaider VK; Mikkelsen LH; Jensen CFS; Sønksen J; Heegaard S
Scand J Urol; 2023 Aug; 58():52-59. PubMed ID: 37635444
[TBL] [Abstract] [Full Text] [Related]
2. Elevated non-coding promoter mutations are associated with malignant transformation of melanocytic naevi to melanoma.
Colebatch AJ; Paver EC; Vergara IA; Thompson JF; Long GV; Wilmott JS; Scolyer RA
Pathology; 2022 Aug; 54(5):533-540. PubMed ID: 35248370
[TBL] [Abstract] [Full Text] [Related]
3. The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma.
Karachaliou GS; Alkallas R; Carroll SB; Caressi C; Zakria D; Patel NM; Trembath DG; Ezzell JA; Pegna GJ; Googe PB; Galeotti JP; Ayvali F; Collichio FA; Lee CB; Ollila DW; Gulley ML; Johnson DB; Kim KB; Watson IR; Moschos SJ
BMC Cancer; 2022 Jan; 22(1):38. PubMed ID: 34986841
[TBL] [Abstract] [Full Text] [Related]
4. Rhoj Is a Novel Target for Progression and Invasion of Glioblastoma by Impairing Cytoskeleton Dynamics.
Wang M; Jiang X; Yang Y; Chen H; Zhang C; Xu H; Qi B; Yao C; Xia H
Neurotherapeutics; 2020 Oct; 17(4):2028-2040. PubMed ID: 32822001
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic risk model construction and molecular marker identification in glioblastoma multiforme based on mRNA/microRNA/long non-coding RNA analysis using random survival forest method.
Wang H; Liu D; Yang J
Neoplasma; 2019 May; 66(3):459-469. PubMed ID: 30784292
[TBL] [Abstract] [Full Text] [Related]
6. Genomic Characterization of Dysplastic Nevi Unveils Implications for diagnosis of Melanoma.
Melamed RD; Aydin IT; Rajan GS; Phelps R; Silvers DN; Emmett KJ; Brunner G; Rabadan R; Celebi JT
J Invest Dermatol; 2017 Apr; 137(4):905-909. PubMed ID: 27890785
[TBL] [Abstract] [Full Text] [Related]
7. Identification of metastasis-suppressive microRNAs in primary melanoma.
Hanniford D; Segura MF; Zhong J; Philips E; Jirau-Serrano X; Darvishian F; Berman RS; Shapiro RL; Pavlick AC; Brown B; Osman I; Hernando E
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25677173
[TBL] [Abstract] [Full Text] [Related]
8. Clinical and pathological associations of the activating rac1 P29S mutation in primary cutaneous melanoma.
Mar VJ; Wong SQ; Logan A; Nguyen T; Cebon J; Kelly JW; Wolfe R; Dobrovic A; McLean C; McArthur GA
Pigment Cell Melanoma Res; 2014 Nov; 27(6):1117-25. PubMed ID: 25043693
[TBL] [Abstract] [Full Text] [Related]
9. [Melanoma: from molecular studies to the treatment breakthrough].
Imianitov EN
Arkh Patol; 2013; 75(5):63-72. PubMed ID: 24341237
[TBL] [Abstract] [Full Text] [Related]
10. Bilateral germ-cell testicular cancer - long-term experience.
Ondruš D; Ondrušová M; Št'astná V
Klin Onkol; 2013; 26(6):421-4. PubMed ID: 24320591
[TBL] [Abstract] [Full Text] [Related]
11. Combined inhibition of HER1/EGFR and rac1 results in a synergistic antiproliferative effect on established and primary cultured human glioblastoma cells.
Karpel-Massler G; Westhoff MA; Zhou S; Nonnenmacher L; Dwucet A; Kast RE; Bachem MG; Wirtz CR; Debatin KM; Halatsch ME
Mol Cancer Ther; 2013 Sep; 12(9):1783-95. PubMed ID: 23832120
[TBL] [Abstract] [Full Text] [Related]
12. The expression of rho proteins decreases with human brain tumor progression: potential tumor markers.
Forget MA; Desrosiers RR; Del M; Moumdjian R; Shedid D; Berthelet F; Béliveau R
Clin Exp Metastasis; 2002; 19(1):9-15. PubMed ID: 11918088
[TBL] [Abstract] [Full Text] [Related]
